Merck & Co Inc (NYSE:MRK)
| 77.15 Delayed Data As of Oct 18 |  -1.18 / -1.51%Today’s Change | 68.38 Today|||52-Week Range 84.56 | -1.09% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 78.33 |
| Today’s open | 78.74 |
| Day’s range | 77.11 - 78.74 |
| Volume | 571,943 |
| Average volume (3 months) | 12,823,812 |
| Market cap | $198.3B |
Data as of 5:56pm ET, 10/18/2021
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | -0.78% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +3.06% |
| P/E ratio | 31.5 |
| Price/Sales | 4.33 |
| Price/Book | 7.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -0.01 | -0.01% |
| NVSNovartis | +0.02 | +0.02% |
| AZNAstraZeneca | -0.93 | -1.54% |
| NVONovo Nordisk | +1.09 | +1.07% |
Data as of 5:44pm ET, 10/18/2021
Financials
| Next reporting date | October 28, 2021 |
| EPS forecast (this quarter) | $1.53 |
| Annual revenue (last year) | $48.0B |
| Annual profit (last year) | $7.1B |
| Net profit margin | 14.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
